Corixa Report issue

Contributed to NME For profit Phase 1 Phase 2 Phase 3
Founded: Seattle WA United States (1994)
Status: Acquired by GlaxoSmithKline (2005)

Organization Overview

First Clinical Trial
1998
NCT00022958
First Marketed Drug
2003
tositumomab (bexxar)
First NDA Approval
2003
tositumomab (bexxar)
Last Known Activity
2004

Timeline

NOW
  • Now

Mergers & Acquisitions

Historical Acquisition Tree

Alternative names

Corixa Corporation